D. Biedenbach

发表

Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).

R. Jones, A. Bolmstrôm, C. Ballow, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methods.

R. Jones, D. Biedenbach, 2001, Diagnostic microbiology and infectious disease.

In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes

R. Jones, D. Biedenbach, 1995, Antimicrobial agents and chemotherapy.

Antimicrobial Characterization of CEM-101: Activity Against Staphylococci, β-Haemolytic and Viridans Group Streptococci

H. Sader, R. Jones, D. Biedenbach, 2009 .

The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.

R. Jones, D. Biedenbach, 1996, Diagnostic microbiology and infectious disease.

Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.

R. Jones, K. A. Gordon, D. Biedenbach, 2004, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.

R. Jones, H. Sader, D. Biedenbach, 2001, Brazilian Journal of Infectious Diseases.

Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing, Fluoroquinolone-Resistant Isolates of Klebsiella pneumoniae in Taiwan

M. Pfaller, R. Jones, S. Messer, 2002, Journal of Clinical Microbiology.

Update of the Activity of Cefditoren and Comparator Oral β-lactam Agents Tested Against Community-Acquired Streptococcus pneumoniae Isolates (USA, 2004-2006)

T. Fritsche, R. Jones, D. Biedenbach, 2008, Journal of chemotherapy.

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents

R. Jones, D. Biedenbach, 1997, Journal of clinical microbiology.

In Vitro Evaluation of BI 397, a Novel Glycopeptide Antimicrobial Agent

M. Pfaller, R. Jones, D. M. Johnson, 2001, Journal of chemotherapy.

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli.

W. Howard, R. Jones, D. Biedenbach, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Tigecycline Activity Tested Against Commonly Isolated Skin and Skin Structure Infection (cSSSI) Pathogens: 2009 USA Surveillance Results

H. Sader, D. Farrell, R. Jones, 2010 .

Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).

R. Jones, D. Biedenbach, 2000, Diagnostic microbiology and infectious disease.

Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1

G. Doern, R. Jones, J. Washington, 1995, Journal of clinical microbiology.

Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks

R. Jones, L. Zerva, D. Biedenbach, 1996, Journal of clinical microbiology.

Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration

R. Jones, D. Biedenbach, 1996, Journal of clinical microbiology.

Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.

M. Pfaller, R. Jones, D. M. Johnson, 2000, Diagnostic microbiology and infectious disease.